Protego Rx Leads the Way
ProtegoRx is transforming how specialty drug costs are managed through the Protego Specialty Product (PSP)—a next-generation approach that drives biosimilar adoption, eliminates rebate distortion, and aligns incentives across the board.
We work directly with manufacturers to deliver better pricing through exclusive contracts and aggregated demand. Whether you’re an employer, payer, or provider, PSP gives you the tools to reduce costs, improve patient access, and make informed decisions based on real-world data.
Key Benefits
Cut specialty drug costs through smarter biosimilar utilization
Switch to transparent and straightforward pricing options with no hidden fees
Regain control from traditional PBM and rebate-driven systems
Align savings directly with your organization—not intermediaries
Our Proven Process
From consultation to support — here is everything that we can do for your organization:
Consultation
We evaluate your current specialty drug strategy and identify biosimilar opportunities across key categories like oncology, autoimmune, and endocrinology.
Customization
You select a model that best fits your organization. Full transparency, no markups, no surprises.
Implementation
We handle manufacturer contracting, negotiate pass-through pricing, and structure your biosimilar program for fast, scalable adoption.
Ongoing Support
Receive detailed analytics on biosimilar uptake, clinical outcomes, and savings impact—plus education for providers and benefits teams to drive long-term value.
Ready to Optimize Your Specialty Pharmacy Spend? Email us.
info@protegorx.com